Estrogen Patch Shortages Likely Driven By Empowered Women Seeking Relief, Expert Says
via HealthDayMONDAY, April 27, 2026 — A new generation of empowered women could be driving the estrogen patch shortages now bedeviling the United States, the medical director of The Menopause Society told HealthDay TV.
“I think it's that women and clinicians and people in general are talking about menopause much more so now than in the past, which is a good thing,” said Dr. Stephanie Faubion, who is also director of the Mayo Clinic Center for Women’s Health.
“This is a different generation than the baby boomers who really didn't talk about things like menopause in public,” she said. “The Gen Xers and the first of the millennials are now in the age range where they would start to experience symptoms, and hearing that there's nothing that can be done for their symptoms is not acceptable to this generation and you got to love it.
“So, they're not only asking for answers, they're crowdsourcing answers and using social media to do so,” Faubion said. “They're educated. A lot of them have money and their own jobs and they have a need that has not been fulfilled. That vacuum has created an industry around menopause now, which did not exist before.”
More than 1 million women in the U.S. enter menopause every year, and many seek help for symptoms like hot flashes, mood changes and sleep problems, HealthDay has reported.
Interest in hormone replacement therapy (HRT) has grown in recent years, especially since the U.S. Food and Drug Administration (FDA) updated its messaging last year.
In November, FDA removed a long-standing black-box safety warning on these therapies, Reuters reported.
By the end of February, use of estrogen patches jumped 26%, according to data from Truveta, a health analytics company.
Since 2023, estrogen patch use has increased 184%, while use of vaginal creams rose 122%.
Demand in the U.S. for menopause hormone therapy plummeted in the early 2000s, after a large-scale study linked it to an increased risk of heart disease and breast cancer, Faubion said.
But in the subsequent years, re-analysis of the data revealed that “for those women in their 50s, hormone therapy was actually pretty safe,” Faubion said. “And for those women, the risk of heart attack and stroke is quite rare anyway, because these are younger women.”
Overall, hormone therapy use remained under 2% in the U.S., as of 2023, Faubion said.
“We don’t have data over the last year, two years to say there’s been an uptick, but it appears to be the case,” she said.
Despite this increased interest, there are still some women whose health history will impact the type of hormone therapy they get, or if they should get it at all, Faubion said.
“If you're younger than 60 or within 10 years of menopause onset and having bothersome symptoms like hot flashes, night sweats, sleep disturbances, mood disturbances … that would be the woman that we would want to talk about,” she said.
However, doctors also will look at a woman’s health history for signs of heart disease or breast cancer before prescribing hormone therapy, Faubion said.
“If you have, for example, diabetes or high blood pressure, it doesn't mean that you're not a candidate for hormone therapy, but it might affect the type of hormone therapy and the route of delivery that we give to you,” she said.
In the meantime, doctors are figuring out ways to get women the help they need despite estrogen patch shortages, Faubion said.
“Usually if we rewrite the prescription, if they couldn't get the once-a-week patch, we do the twice-a-week patch or we get to the dose in a different way by doing two lower dose patches together,” Faubion said. “So, usually we can cobble it together.”
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-04-28 09:34
Read more
- Your Brain Cares If Your Plant-Based Diet Is Unhealthy, Researchers Report
- New Cervix-On-A-Chip May Revolutionize STI Treatment
- Flu Vaccine Reduces Risk for Cardiovascular Events, Even With Breakthrough Infection
- Never-Married Adults Have Increased Cancer Incidence
- More Than 250,000 Global Deaths From Meningitis Reported in 2023
- Dirty Water Tied to Tympanostomy Tube Otorrhea
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions